Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000145006 | SCV000192042 | likely benign | not specified | 2013-10-29 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV002253240 | SCV002522625 | uncertain significance | Maturity onset diabetes mellitus in young | criteria provided, single submitter | research | Mutations in ABCC8 gene are associated with both neonatal diabetes mellitus as well as MODY. Patients with this mutation may have a better response to sulfonylureas. However, no sufficient evidence is found to ascertain the role of this particular variant ( rs201000679) in MODY yet. | |
Clinical Genomics, |
RCV002273818 | SCV002522626 | uncertain significance | Transitory neonatal diabetes mellitus | criteria provided, single submitter | research | Mutations in ABCC8 gene are associated with both neonatal diabetes mellitus as well as MODY. Patients with this mutation may have a better response to sulfonylureas. However, no sufficient evidence is found to ascertain the role of this particular variant ( rs201000679) in neonatal diabetes yet. | |
New York Genome Center | RCV002467586 | SCV002764519 | uncertain significance | Hyperinsulinemic hypoglycemia, familial, 1; Diabetes mellitus, permanent neonatal 3 | 2022-01-14 | criteria provided, single submitter | clinical testing | The heterozygous c.823-8C>T variant identified in the ABCC8 gene is a non-canonical splicing region variant at the -8 position within intron 5/38. This variant is found with low frequency in gnomAD(v3.1.2)(18 heterozygotes, 0 homozygotes; allele frequency: 1.182e-4) suggesting it is not a common benign variant in the populations represented in that database. In silico splicing algorithms SpliceAI and Transcript inferred Pathogenicity Score (TraP) do not predict this variant has a high probability of altering splicing (SpliceAI delta:0.08 (Acceptor Gain, -8bp); TraP Score 0.038 (25-50% score-percentile)). This variant was reported by a single lab in 2013 as Likely Benign in ClinVar (VarID:157708), although the evidence used for that classification was not available for review. To our current knowledge this variant has not been reported in affected individuals in the literature. Given the lack of compelling evidence for its pathogenicity, the heterozygous c.823-8C>T variant identified in the ABCC8 gene is reported as a Variant of Uncertain Significance. |
Labcorp Genetics |
RCV002514783 | SCV003452935 | likely benign | not provided | 2024-01-09 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004532639 | SCV004711086 | likely benign | ABCC8-related disorder | 2020-12-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |